Effects of Interleukin-3 on Myelosuppression Induced by Chemotherapy for Ovarian Cancer and Small Cell Undifferentiated Tumours

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1993.468
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Experimentail Studies on the Prevention of Myelosuppression During Cancer Chemotherapy

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1987English

Glutathione S-Transferase Activity and Isoenzyme Composition in Benign Ovarian Tumours, Untreated Malignant Ovarian Tumours, and Malignant Ovarian Tumours After Platinum/Cyclophosphamide Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1992English

Metallothionein Levels in Ovarian Tumours Before and After Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1991English

Chemotherapy in Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1990English

Chemotherapy of Chemically-Induced Colorectal Tumours

Journal of the Royal Society of Medicine
Medicine
1983English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: The Heat Is On

Cancer
Cancer ResearchOncology
2019English

Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy